Guides

Berberine picked up the nickname "nature's Ozempic" on TikTok. The two compounds act on different targets, and the meta-analysis that looked directly at body weight found no significant effect.

What the Ozempic, Wegovy, Mounjaro and Zepbound labels actually say about the fridge, the counter, a hot car, a freezer, and an airport checkpoint. Each answer is in the first sentence, because you are probably reading this in a hurry.

Every legal route to semaglutide runs through a licensed prescriber and a licensed pharmacy. This is the decision tree: how legitimate telehealth flows work, brand versus compounded, and the red flags that mark an illegal seller.

A weight plateau on semaglutide or tirzepatide has four separate causes, and they do not share an answer. Here is how to tell which one you are looking at, using what the STEP and SURMOUNT trials actually measured.

Clinical trials show 14.9-20.7% body weight loss with semaglutide depending on dose. Standard Wegovy (2.4mg): 14.9-17% over 68 weeks. Wegovy HD (7.2mg, FDA-approved March 2026): 20.7% over 72 weeks. Month-by-month breakdown from the STEP trials.

Verified May 2026: Tirzepatide starts at 2.5 mg once weekly (non-therapeutic starter dose), escalates by 2.5 mg every 4 weeks to a maximum of 15 mg once weekly. Full escalation takes 20 weeks. At 72 weeks, the 15 mg dose produced 20.9% body weight loss in SURMOUNT-1, equivalent to roughly 47 lbs for a 225-lb person. The 5 mg and 10 mg doses are also valid long-term maintenance doses (15% and 19.5% weight loss respectively). Same dosing schedule applies to Zepbound, Mounjaro, and compounded tirzepatide.

Updated August 14, 2026: Foundayo (orforglipron) is Lilly's FDA-approved non-peptide GLP-1 pill. LillyDirect self-pay is $149 at 0.8 mg, $199 at 2.5 mg, $299 at 5.5 or 9 mg, and $299 at 14.5 or 17.2 mg with a refill within 45 days, otherwise $349. No fasting is required.

FDA-approved GLP-1 receptor agonists for weight loss, 2026 guide. Eligibility: BMI 30+ (or 27+ with comorbidity). Semaglutide produces 14.9% weight loss (STEP-1), tirzepatide 20.9% (SURMOUNT-1). Cost: $25-$349/mo via telehealth. Complete 5-step prescription process with verified provider pricing. Options: Foundayo (orforglipron), oral Wegovy, Zepbound, and injectable semaglutide.

Verified August 7, 2026: NovoCare lists the brand-name Wegovy pen at $199/mo for the first two low-dose fills, then $349/mo at standard strengths ($399 for HD) and the oral pill from $149/mo, dose-dependent; Zepbound starts at $299/mo via LillyDirect. Compounded offerings may advertise lower prices but require product- and prescription-specific regulatory review.

Verified July 2026: GLP-1 patients lose 2-5 pounds in their first month. Appetite suppression starts week 1-2. Nausea peaks at week 4 dose escalation. 98.1% of GI side effects are mild-to-moderate per STEP-1 and SURMOUNT-1 trials. Complete week-by-week timeline with dosing schedule.

GLP-1 patches sold online don't contain semaglutide or tirzepatide, they're herbal supplements. Here's what the science says and what actually works.